Eaton Vance Management Alnylam Pharmaceuticals, Inc. Transaction History

Eaton Vance Management

  • $67.5 Billion
  • Q3 2022

A detailed history of Eaton Vance Management transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 307,288 shares of ALNY stock, worth $132 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
307,288
Previous 306,751 0.18%
Holding current value
$132 Million
Previous $44.7 Million 37.48%
% of portfolio
0.09%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $74,395 - $124,584
537 Added 0.18%
307,288 $61.5 Million
Q2 2022

Aug 15, 2022
BUY
$120.42 - $169.29 $62,979 - $88,538
523 Added 0.17%
306,751 $44.7 Million
Q1 2022

May 16, 2022
BUY
$127.18 - $173.91 $33.4 Million - $45.7 Million
262,893 Added 606.65%
306,228 $50 Million
Q4 2021

Feb 14, 2022
SELL
$159.56 - $209.29 $107,543 - $141,061
-674 Reduced 1.53%
43,335 $7.31 Million
Q3 2021

Nov 15, 2021
BUY
$169.75 - $207.73 $427,430 - $523,064
2,518 Added 6.07%
44,009 $8.29 Million
Q2 2021

Aug 16, 2021
SELL
$128.63 - $176.89 $563,142 - $774,424
-4,378 Reduced 9.54%
41,491 $7.03 Million
Q1 2021

May 17, 2021
SELL
$126.83 - $175.69 $13.2 Million - $18.2 Million
-103,799 Reduced 69.35%
45,869 $6.48 Million
Q4 2020

Feb 12, 2021
SELL
$122.97 - $147.0 $7.91 Million - $9.45 Million
-64,315 Reduced 30.06%
149,668 $19.5 Million
Q3 2020

Nov 13, 2020
SELL
$121.19 - $165.49 $817,184 - $1.12 Million
-6,743 Reduced 3.05%
213,983 $31.2 Million
Q2 2020

Aug 13, 2020
BUY
$104.21 - $156.44 $11,671 - $17,521
112 Added 0.05%
220,726 $32.7 Million
Q1 2020

May 14, 2020
BUY
$93.12 - $133.99 $3,166 - $4,555
34 Added 0.02%
220,614 $24 Million
Q4 2019

Feb 11, 2020
SELL
$74.51 - $124.23 $1,788 - $2,981
-24 Reduced 0.01%
220,580 $25.4 Million
Q2 2019

Aug 16, 2019
SELL
$65.86 - $92.79 $8.64 Million - $12.2 Million
-131,129 Reduced 37.28%
220,604 $16 Million
Q1 2019

May 14, 2019
BUY
$72.76 - $93.45 $22.8 Million - $29.3 Million
313,942 Added 830.73%
351,733 $32.9 Million
Q2 2018

Aug 10, 2018
BUY
$88.31 - $107.8 $86,102 - $105,105
975 Added 2.65%
37,791 $3.72 Million
Q1 2018

May 07, 2018
SELL
$115.92 - $148.54 $5,796 - $7,427
-50 Reduced 0.14%
36,816 $4.39 Million
Q4 2017

Feb 12, 2018
BUY
$114.49 - $139.98 $572,450 - $699,900
5,000 Added 15.69%
36,866 $4.68 Million
Q3 2017

Nov 13, 2017
BUY
$72.53 - $118.27 $2.31 Million - $3.77 Million
31,866
31,866 $3.74 Million

Others Institutions Holding ALNY

# of Institutions
745
Shares Held
111M
Call Options Held
916K
Put Options Held
841K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $52.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email